Get the Stockscreener App
14.77
1.07%
-0.16
After Hours:
14.77
Ceribell Inc stock is traded at $14.77, with a volume of 425.30K.
It is down -1.07% in the last 24 hours and down -27.67% over the past month.
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.
See More
Previous Close:
$14.93
Open:
$15.14
24h Volume:
425.30K
Relative Volume:
1.73
Market Cap:
$522.60M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+1.37%
1M Performance:
-27.67%
6M Performance:
-43.95%
1Y Performance:
+0.00%
1-Day Range:
$14.01
$15.61
1-Week Range:
$14.01
$15.61
52-Week Range:
$10.01
$32.75
Ceribell Inc Stock (CBLL) Company Profile
Name
Ceribell Inc
Sector
Industry
Phone
(800) 436-0826
Address
360 N. PASTORIA AVENUE, SUNNYVALE
Compare CBLL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CBLL
Ceribell Inc
|
14.77 | 522.60M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
131.73 | 218.91B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.05 | 139.37B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
348.12 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
83.37 | 106.90B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.60 | 41.45B | 5.72B | 4.17B | 259.90M | 6.97 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-04-25 | Initiated | Ladenburg Thalmann | Buy |
| Nov-05-24 | Initiated | BofA Securities | Buy |
| Nov-05-24 | Initiated | Canaccord Genuity | Buy |
| Nov-05-24 | Initiated | JP Morgan | Overweight |
| Nov-05-24 | Initiated | TD Cowen | Buy |
| Nov-05-24 | Initiated | William Blair | Outperform |
View All
Ceribell Inc Stock (CBLL) Latest News
CeriBell (NASDAQ:CBLL) Trading Down 2.9% on Insider Selling - Defense World
Ceribell's Retail Popularity Surges After Small-Cap Medtech Firm Assures No Tariff Impact Until Q4 - MSN
Alliancebernstein L.P. Invests $532,000 in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell wins FDA nod for algorithm to detect pediatric seizures - MedTech Dive
Ceribell, Inc.: Promising Growth Trajectory and Strong Market Potential Reinforce Buy Rating - TipRanks
Vanguard Group Inc. Takes $18.02 Million Position in CeriBell (NASDAQ:CBLL) - Defense World
CBLL Stock Falls Despite FDA Clearance for Pediatric Clarity Algorithm - MSN
FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older - markets.businessinsider.com
Ceribell announces FDA grants clearance for next-gen Ceribell Clarity algorithm - TipRanks
CeriBell Says FDA Clears Electrographic Seizure Detection Algorithm - marketscreener.com
FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric - GlobeNewswire
Groundbreaking FDA Approval: Ceribell's AI Now Detects Seizures in Children Within Minutes - Stock Titan
Corebridge Financial Inc. Buys Shares of 6,122 CeriBell (NASDAQ:CBLL) - Defense World
Norges Bank Takes Position in CeriBell (NASDAQ:CBLL) - Defense World
CeriBell (NASDAQ:CBLL) Shares Gap Up – Still a Buy? - Defense World
Ceribell Reports Fourth Quarter and Full Year 2024 Financial Results - ADVFN
Ceribell braces for tariff impact on margins By Investing.com - Investing.com Canada
CeriBell's Stock Climbs As Tariff Relief Extends To 2025 - Finimize
Sector Update: Health Care - TradingView
CeriBell Shares Jump After Claiming Inventory in US Provides Buffer From Tariffs Until Q4 - MarketScreener
William Blair maintains Ceribell Outperform amid tariff concerns By Investing.com - Investing.com Canada
Canaccord maintains Ceribell stock buy rating, $33 target By Investing.com - Investing.com South Africa
William Blair maintains Ceribell Outperform amid tariff concerns - Investing.com Australia
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Canaccord maintains Ceribell stock buy rating, $33 target - Investing.com
Ceribell, Inc.: Strategic Resilience and Financial Health Amid Market Challenges - TipRanks
Ceribell braces for tariff impact on margins - Investing.com Australia
Data-Based Insights About Ceribell Inc (CBLL) - stocksregister.com
Ceribell, Inc. Addresses Impact of New U.S. Tariffs - TipRanks
CeriBell addresses impact of new U.S. tariffs on Chinese imports - grafa.com
institutional investors of CeriBell, Inc. (NASDAQ:CBLL) must be disappointed after last week's 40% drop - simplywall.st
Ceribell, Inc.: Strategic Maneuvers Boost Gross Margin Amid Tariff Challenges, Supporting Buy Rating - TipRanks
Ceribell, Inc.: Strong Financial Position and Strategic Management Justify Buy Rating Amid Tariff Challenges - TipRanks
CeriBell, Inc.Common Stock (NQ: CBLL - FinancialContent
With 49% stake, CeriBell, Inc. (NASDAQ:CBLL) seems to have captured institutional investors' interest - Yahoo Finance
CeriBell's IPO Lockup Ends April 9Here's Why We're Shorting It Today (NASDAQ:CBLL) - Seeking Alpha
CeriBell (NASDAQ:CBLL) Receives $32.60 Average PT from Brokerages - Defense World
CeriBell (NASDAQ:CBLL) Coverage Initiated by Analysts at LADENBURG THALM/SH SH - Defense World
Ladenburg Thalmann Initiates Coverage of CeriBell (CBLL) with Buy Recommendation - Nasdaq
This Lattice Semiconductor Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
Ladenburg Thalmann Initiates CeriBell at Buy With $32 Price Target - marketscreener.com
Critical Analysis: CeriBell (NASDAQ:CBLL) versus NeurAxis (NASDAQ:NRXS) - Defense World
Reviewing IRIDEX (NASDAQ:IRIX) & CeriBell (NASDAQ:CBLL) - Defense World
CeriBell’s (NASDAQ:CBLL) Lock-Up Period To Expire on April 9th - Defense World
Critical Comparison: CeriBell (NASDAQ:CBLL) and InMode (NASDAQ:INMD) - Defense World
Charles Schwab Investment Management Inc. Invests $2.50 Million in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell Inc Stock (CBLL) Financials Data
There is no financial data for Ceribell Inc (CBLL). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):